Search research articles
Contact Us
Filters
Showing results (121-130 of 143) with videos related to
Page
of 15
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
May 5, 2022
Highly active CAR T cells that bind to a juxtamembrane region of mesothelin and are not blocked by shed mesothelin
Xiufen Liu, Masanori Onda, Nathan Watson, et al.
Elife
|
May 21, 2020
R-spondins engage heparan sulfate proteoglycans to potentiate WNT signaling
Ramin Dubey, Peter van Kerkhof, Ingrid Jordens, et al.
Hepatology (Baltimore, Md.)
|
October 25, 2018
Glypican-3-Specific Antibody Drug Conjugates Targeting Hepatocellular Carcinoma
Ying Fu, Daniel J Urban, Roger R Nani, et al.
Scientific Reports
|
March 5, 2021
Tissue factor pathway inhibitor upregulates CXCR7 expression and enhances CXCL12-mediated migration in chronic lymphocytic leukemia
Xue Yan Cui, Geir Erland Tjønnfjord, Sandip M Kanse, et al.
Cell Reports
|
November 2, 2017
Infectious Entry and Neutralization of Pathogenic JC Polyomaviruses
Eileen M Geoghegan, Diana V Pastrana, Rachel M Schowalter, et al.
Cancer Immunology Research
|
June 26, 2025
GPC2-Targeted CAR T Cells Engineered with NFAT-Inducible Membrane-Tethered IL15/IL21 Exhibit Enhanced Activity against Neuroblastoma
Reona Okada, Jeyshka M Reyes-González, Constanza Rodriguez, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 30, 2023
Site-Specifically Conjugated Single-Domain Antibody Successfully Identifies Glypican-3-Expressing Liver Cancer by Immuno-PET
Stanley Fayn, A Paden King, Nicholas T Gutsche, et al.
Molecular Therapy. Oncology
|
October 29, 2025
GPC2-CAR T cells have potent preclinical activity against orthotopic medulloblastoma xenografts
Reona Okada, Mia Fanuzzi, Constanza Rodriguez, et al.
Cell Reports. Medicine
|
September 30, 2025
Antibody-gamma/delta T cell receptors targeting GPC2 regress neuroblastoma with low antigen density
Alex Quan, Mingyu Huo, Dan Li, et al.
Biorxiv : the Preprint Server for Biology
|
November 9, 2021
Camel nanobodies broadly neutralize SARS-CoV-2 variants
Jessica Hong, Hyung Joon Kwon, Raul Cachau, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 143) with videos related to
Sort By:
Page
of 15
Proceedings of the National Academy of Sciences of the United States of America
|
May 5, 2022
Highly active CAR T cells that bind to a juxtamembrane region of mesothelin and are not blocked by shed mesothelin
Xiufen Liu, Masanori Onda, Nathan Watson, et al.
Elife
|
May 21, 2020
R-spondins engage heparan sulfate proteoglycans to potentiate WNT signaling
Ramin Dubey, Peter van Kerkhof, Ingrid Jordens, et al.
Hepatology (Baltimore, Md.)
|
October 25, 2018
Glypican-3-Specific Antibody Drug Conjugates Targeting Hepatocellular Carcinoma
Ying Fu, Daniel J Urban, Roger R Nani, et al.
Scientific Reports
|
March 5, 2021
Tissue factor pathway inhibitor upregulates CXCR7 expression and enhances CXCL12-mediated migration in chronic lymphocytic leukemia
Xue Yan Cui, Geir Erland Tjønnfjord, Sandip M Kanse, et al.
Cell Reports
|
November 2, 2017
Infectious Entry and Neutralization of Pathogenic JC Polyomaviruses
Eileen M Geoghegan, Diana V Pastrana, Rachel M Schowalter, et al.
Cancer Immunology Research
|
June 26, 2025
GPC2-Targeted CAR T Cells Engineered with NFAT-Inducible Membrane-Tethered IL15/IL21 Exhibit Enhanced Activity against Neuroblastoma
Reona Okada, Jeyshka M Reyes-González, Constanza Rodriguez, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 30, 2023
Site-Specifically Conjugated Single-Domain Antibody Successfully Identifies Glypican-3-Expressing Liver Cancer by Immuno-PET
Stanley Fayn, A Paden King, Nicholas T Gutsche, et al.
Molecular Therapy. Oncology
|
October 29, 2025
GPC2-CAR T cells have potent preclinical activity against orthotopic medulloblastoma xenografts
Reona Okada, Mia Fanuzzi, Constanza Rodriguez, et al.
Cell Reports. Medicine
|
September 30, 2025
Antibody-gamma/delta T cell receptors targeting GPC2 regress neuroblastoma with low antigen density
Alex Quan, Mingyu Huo, Dan Li, et al.
Biorxiv : the Preprint Server for Biology
|
November 9, 2021
Camel nanobodies broadly neutralize SARS-CoV-2 variants
Jessica Hong, Hyung Joon Kwon, Raul Cachau, et al.
Page
of 15